| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/24/2008 | US20080176249 GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity |
| 07/24/2008 | US20080176243 Designing vector system comprising regulatory sequences which utilize human chorionic gonadotropin and/or nuclear factor kappaB as modulators of genic expression |
| 07/24/2008 | US20080176231 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders |
| 07/24/2008 | US20080175971 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 07/24/2008 | US20080175896 high affinity to a fibroblast growth factor-inducible 14 (Fn14) cell surface receptor; induce cell death; drug target at diseased cell of cancer, atherosclerosis, stroke, lupus, nephritis, multiple sclerosis, rheumatoid arthritis, degenerative or inflammation; reduce side effect |
| 07/24/2008 | US20080175883 Self-assembling peptide amphiphiles |
| 07/24/2008 | US20080175878 Protease for activating clotting factor VII |
| 07/24/2008 | US20080175871 Eliciting improved immune responses |
| 07/24/2008 | US20080175867 genetic engineered proteins useful as immunogens in vaccines; prevention of periodontal disease |
| 07/24/2008 | US20080175866 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms |
| 07/24/2008 | US20080175859 Recombinant infectious laryngotracheitis virus and uses thereof |
| 07/24/2008 | US20080175857 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 07/24/2008 | US20080175856 Enterococcus Antigens |
| 07/24/2008 | US20080175854 Point mutations; antibodies; fusion proteins |
| 07/24/2008 | US20080175853 Virus-like particles for the induction of autoantibodies |
| 07/24/2008 | US20080175849 Monoclonal antibody for use in diagnosis, prevention and treatment of infectious mononucleosis and cell proliferative disorders |
| 07/24/2008 | US20080175843 Nucleotide sequences coding osteoblast activating factor (OAF) for use in diagnosis, prevention and treatment of inflammatory, periodontal and infectious diseases |
| 07/24/2008 | US20080175842 Compositions and methods for treatment |
| 07/24/2008 | US20080175840 Methods for treating angiogenesis related disorders |
| 07/24/2008 | US20080175839 Compositions Against Cancer Antigen LIV-1 and Uses Thereof |
| 07/24/2008 | US20080175828 Proliferated cell lines and uses thereof |
| 07/24/2008 | US20080175819 Vector system |
| 07/24/2008 | US20080175818 Using replication-defective plasmid comprising p53 nucleotide sequences as as delivery tool for antitumor agents |
| 07/24/2008 | US20080175789 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits |
| 07/24/2008 | US20080175788 Analyzing for changes in levels of cancer specific genes (CSG) in cells, tissues or bodily fluids compared with levels of CSG in preferably the same cells, tissues, or bodily fluid type of a normal human control: administering antibodies conjugated to cytotoxic agents, which specifically bind CSG |
| 07/24/2008 | CA2676308A1 Recombinant malaria vaccine |
| 07/24/2008 | CA2675968A1 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 07/24/2008 | CA2675754A1 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 07/24/2008 | CA2675364A1 Convenient method for inhibition of gene expression using rsis |
| 07/24/2008 | CA2674552A1 Vaccine |
| 07/24/2008 | CA2674458A1 Fusion protein |
| 07/24/2008 | CA2674445A1 Gp100-specific t cell receptors and related materials and methods of use |
| 07/24/2008 | CA2673516A1 Method of purifying apolipoprotein a-1 |
| 07/24/2008 | CA2672091A1 Disintegrin variants and pharmaceutical uses thereof |
| 07/24/2008 | CA2667678A1 Toxin peptide therapeutic agents |
| 07/23/2008 | EP1947459A2 Differential immunoassay |
| 07/23/2008 | EP1947201A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 07/23/2008 | EP1947187A1 Hybrid expression of neisserial proteins |
| 07/23/2008 | EP1947185A1 HCV NS3/4A encoding nucleic acid |
| 07/23/2008 | EP1947184A2 Delta-endotoxin genes and methods for their use |
| 07/23/2008 | EP1947183A1 Mammalian cell surface antigens; related reagents |
| 07/23/2008 | EP1947182A1 Fibroblast growth factor-23 molecules and uses thereof |
| 07/23/2008 | EP1947181A1 Mutant paramyxovirus and method for production thereof |
| 07/23/2008 | EP1947174A1 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 07/23/2008 | EP1947118A1 VEGF traps and therapeutic uses thereof |
| 07/23/2008 | EP1947117A2 Glycoprotein hormone superagonists |
| 07/23/2008 | EP1947116A2 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 07/23/2008 | EP1947115A2 Combination of glycoisoforms for the treatment or prevention of septicemia, transgenic cell line that produces erythropoietin glycoisoforms, pharmaceutical composition comprising said combination, method of obtaining the cell line, method of producing the combination of glycoisoforms and methods for the treatment and preven |
| 07/23/2008 | EP1947114A1 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 07/23/2008 | EP1947113A1 P53 binding polypeptide |
| 07/23/2008 | EP1947112A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2008 | EP1947111A1 Novel mucin glycoprotein and use thereof |
| 07/23/2008 | EP1947110A1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli |
| 07/23/2008 | EP1947109A2 Biologically active peptides |
| 07/23/2008 | EP1946770A1 Uses of DC-sign and DC-signr for inhibiting hepatitis C virus infection |
| 07/23/2008 | EP1946768A1 Outer coat protein pa5158 of pseudomonas aeruginosa |
| 07/23/2008 | EP1946749A1 Anti-angionene compositions and methods of use |
| 07/23/2008 | EP1945805A2 Method using human or mouse isg12 for the development and production of medicaments and single nucleotide polymorphism in the isg12 gene for diagnostic purposes |
| 07/23/2008 | EP1945790A2 Vasoactive intestinal polypeptide pharmaceuticals |
| 07/23/2008 | EP1945778A2 Multi-plasmid system for the production of influenza virus |
| 07/23/2008 | EP1945776A2 Dof (dna binding with one finger) sequences and methods of use |
| 07/23/2008 | EP1945775A2 Method for the production of gamma-linolenic acid and/or stearidonic acid in transgenic brassicaceae and linaceae |
| 07/23/2008 | EP1945767A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies |
| 07/23/2008 | EP1945760A1 Productivity augmenting protein factor, novel cell lines and uses thereof |
| 07/23/2008 | EP1945691A2 Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same |
| 07/23/2008 | EP1945673A2 Targeting and tracing of antigens in living cells |
| 07/23/2008 | EP1945663A1 Insulin-like growth factor ii (igf-ii) binding factors |
| 07/23/2008 | EP1945662A2 Methods for production of receptor and ligand isoforms |
| 07/23/2008 | EP1945661A1 Gpr 146 receptor |
| 07/23/2008 | EP1945660A1 Library from toxin mutants, and methods of using same |
| 07/23/2008 | EP1945659A2 Influenza viruses able to infect canids, uses thereof |
| 07/23/2008 | EP1945658A2 Diastereomeric peptides for modulating t cell immunity |
| 07/23/2008 | EP1945657A2 Tlr3 glycosylation site muteins and methods of use |
| 07/23/2008 | EP1945656A2 Nanocomposites of repeat sequence proteins and phyllosilicate clays and their preparation |
| 07/23/2008 | EP1945263A2 Metal-binding therapeutic peptides |
| 07/23/2008 | EP1945259A2 Fusion proteins for blood-brain barrier delivery |
| 07/23/2008 | EP1945258A2 Tdf-related compounds and analogs thereof |
| 07/23/2008 | EP1945256A1 Methods and compositions for modulating wound repair |
| 07/23/2008 | EP1945255A2 Radiating element for radar array antenna |
| 07/23/2008 | EP1945250A2 Influenza recombinant subunit vaccine |
| 07/23/2008 | EP1945248A2 Compositions and methods for the detection of trypanosoma cruzi infection |
| 07/23/2008 | EP1945245A2 Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| 07/23/2008 | EP1907419A4 Preparation of insulin conjugates |
| 07/23/2008 | EP1745070A4 Peptide stabilization |
| 07/23/2008 | EP1608962A4 Model for neurodegenerative disorders |
| 07/23/2008 | EP1573314B1 Transgenic mice expressing human cd20 |
| 07/23/2008 | EP1468023B1 Binding proteins as biosensors |
| 07/23/2008 | EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 07/23/2008 | EP1356030B1 Runx3 gene showing anti-tumor activity and use thereof |
| 07/23/2008 | EP1345743B1 Electroprocessed collagen |
| 07/23/2008 | EP1328287B1 Compositions and methods for wt1 specific immunotherapy |
| 07/23/2008 | EP1311701B1 Use of b-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| 07/23/2008 | EP1278829B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 07/23/2008 | EP1248841B1 Genes differentially expressed in breast cancer |
| 07/23/2008 | EP1165797B1 Particles for gene therapy |
| 07/23/2008 | EP1155131B1 Vector comprising a splice acceptor trap and a poly a trap and the corresponding eukaryotic host cells |
| 07/23/2008 | EP1123383B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 07/23/2008 | EP1082413B1 Aav5 vector and uses thereof |
| 07/23/2008 | EP1068339B1 Compositions and methods for protein secretion |
| 07/23/2008 | EP1032688B1 Single-chain bifunctional glycoprotein hormones |